Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
AbCellera Biologics Inc. (ABCL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 56,125 options to buy
@ $2.7, valued at
$151.5k
|
|
| 08/09/2023 |
4
| Hayden Michael R (Director) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 30,000 shares
@ $5.9, valued at
$177k
|
|
| 05/26/2023 |
4
| Booth Andrew (CFO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 14,500 shares
@ $6.85, valued at
$99.3k
|
|
| 05/26/2023 |
4
| Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 153,000 shares
@ $6.5211, valued at
$997.7k
|
|
| 05/09/2023 |
4
| Lecault Veronique (COO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 250,000 options to buy
@ $0.19, valued at
$47.5k
|
|
| 02/23/2023 |
4
| Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 56,125 options to buy
@ $2.7, valued at
$151.5k
|
|
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/22/2022 |
4
| Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 200,000 shares
@ $11.4623, valued at
$2.3M
|
|
| 08/22/2022 |
4
| Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 56,125 options to buy
@ $2.7, valued at
$151.5k
|
|
| 06/15/2022 |
4
| Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 54,915 shares
@ $8.0318, valued at
$441.1k
Bought 9,173 shares
@ $8.0499, valued at
$73.8k
|
|
| 06/08/2022 |
4
| Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 64,545 shares
@ $7.4981, valued at
$484k
|
|
| 05/19/2022 |
4
| Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 56,125 options to buy
@ $2.7, valued at
$151.5k
|
|
| 05/17/2022 |
4
| Lecault Veronique (COO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 200,000 shares
@ $6.3389, valued at
$1.3M
|
|
| 05/17/2022 |
4
| Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 300,000 shares
@ $7.2551, valued at
$2.2M
|
|
| 05/16/2022 |
4
| Thermopylae Holdings Ltd. (10% Owner) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 1,408,468 shares
@ $6.4054, valued at
$9M
|
|
| 05/16/2022 |
4
| Booth Andrew (CFO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 85,000 shares
@ $5.79, valued at
$492.2k
|
|
| 03/04/2022 |
4
| Montalbano John S. (Director) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 10,000 shares
@ $8.54, valued at
$85.4k
|
|
| 03/03/2022 |
4
| Montalbano John S. (Director) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 20,000 shares
@ $9.05, valued at
$181k
|
|
| 03/01/2022 |
4
| Lecault Veronique (COO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 230,789 shares
@ $8.66, valued at
$2M
|
|
| 02/25/2022 |
4
| Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 56,125 options to buy
@ $2.7, valued at
$151.5k
|
|
| 12/10/2021 |
4
| Booth Andrew (CFO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 500,000 options to buy
@ $0.32, valued at
$160k
|
|
| 12/10/2021 |
4
| Montalbano John S. (Director) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Granted 34,282 options to buy
@ $17.58, valued at
$602.7k
Granted 45,532 options to buy
@ $14.55, valued at
$662.5k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2021 |
4
| Lecault Veronique (COO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Granted 406,020 options to buy
@ $14.55, valued at
$5.9M
|
|
|
|
|